Safety endpoints well demonstrated now. It halts the disease but not reverses it? Sounds saleable to me! Larger commercial funded study under medsafe supervision smells like what they were after at the presentation.
- Forums
- ASX - By Stock
- Ann: NTCELL Parkinsons trial patient data 2 years after implant
Safety endpoints well demonstrated now. It halts the disease but...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AI (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.001(16.7%) |
Mkt cap ! $11.81M |
Open | High | Low | Value | Volume |
0.6¢ | 0.7¢ | 0.6¢ | $746 | 107.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 5265293 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 90900 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 5265293 | 0.006 |
13 | 5177919 | 0.005 |
6 | 3695009 | 0.004 |
2 | 3100000 | 0.003 |
2 | 1050000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 90900 | 1 |
0.008 | 2252112 | 10 |
0.009 | 1828673 | 9 |
0.010 | 4020149 | 6 |
0.011 | 909287 | 4 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |